Zobrazeno 1 - 10
of 15
pro vyhledávání: '"B. Diane Reams"'
Autor:
Karynsa Cetin, B. Diane Reams, Rohini K. Hernandez, Anne M. Butler, Amy P. Abernethy, Alexander Liede, Robert A. Overman, Jung In Kim, Bradford R. Hirsch, M. Alan Brookhart
Publikováno v:
Pharmacoepidemiology and Drug Safety. 27:229-238
Purpose To examine the dynamics of treatment with 2 bone-targeting agents (BTAs)-denosumab and zoledronic acid-among men with bone metastases from prostate cancer. Methods Using electronic health record data from oncology practices across the US, we
Autor:
Jonathan V. Todd, Xiaojuan Li, Virginia Pate, Abhijit V. Kshirsagar, B. Diane Reams, MA Brookhart
Publikováno v:
Annals of Epidemiology. 24:754-761
To examine the extent to which commonly ordered laboratory values obtained from large health care databases are representative of the distribution of laboratory values from the general population as reflected in the National Health and Nutrition Exam
Autor:
Cathy W. Critchlow, Julie C. Lauffenburger, Cynthia D. O'Malley, M. Alan Brookhart, B. Diane Reams
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:251-260
Purpose Newly marketed medications may be used selectively in patients with more severe disease. Changes in patterns of use following a drug's introduction to the market can greatly influence results from non-experimental comparative effectiveness re
Autor:
B. Diane Reams, Shannon J. McCall, Timothy A. Fields, Scott M. Palmer, David N. Howell, Victor L. Roggli
Publikováno v:
The Journal of Heart and Lung Transplantation. 24:624-627
Intravenous injection of drugs that contain insoluble foreign material can lead to pulmonary embolization of the material and can have devastating results, including pulmonary hypertension and death. Most cases are detected after the onset of extensi
Autor:
David N. Howell, R. Duane Davis, Scott M. Palmer, H. Page McAdams, B. Diane Reams, Mark P. Steele
Publikováno v:
Chest. 124:1242-1249
Introduction Posttransplant lymphoproliferative disorder (PTLD) is a relatively infrequent but devastating complication that occurs after solid-organ transplantation. Although the optimal treatment for this condition is unknown, rituximab, a murine/h
Autor:
B. Diane Reams, Scott M. Palmer
Publikováno v:
American Journal of Respiratory Medicine. 1:91-98
Lung transplantation has emerged as an option to prolong and increase the quality of life in patients with end-stage pulmonary lung disease. In lung transplant recipients, because of the high potential for acute and chronic allograft rejection, optim
Autor:
B Diane, Reams, Cynthia D, O'Malley, Cathy W, Critchlow, Julie C, Lauffenburger, M Alan, Brookhart
Publikováno v:
Pharmacoepidemiology and drug safety. 23(3)
Newly marketed medications may be used selectively in patients with more severe disease. Changes in patterns of use following a drug's introduction to the market can greatly influence results from non-experimental comparative effectiveness research.
Autor:
Bradford R. Hirsch, Karynsa Cetin, Alexander Liede, B. Diane Reams, M. Alan Brookhart, Anne M. Butler, Rohini K. Hernandez, JungIn Kim, Amy P. Abernethy, Robert A. Overman
Publikováno v:
Journal of Clinical Oncology. 34:e13083-e13083
e13083Background: Bone metastases (BM) are common in advanced prostate cancer patients and can lead to serious skeletal-related events (eg, pathological fracture). Two bone-targeting agents (BTAs) ...
Autor:
Scott M. Palmer, B. Diane Reams, Mark P. Steele, Robert H. Messier, Dan C Grinnan, R. Duane Davis
Publikováno v:
Clinical transplantation. 18(2)
Cytomegalovirus (CMV) is a common opportunistic infection in lung transplant recipients. Despite the use of early post-operative intravenous ganciclovir, most high-risk patients develop CMV infection. We conducted this retrospective study to determin
Autor:
B Diane, Reams, H Page, McAdams, David N, Howell, Mark P, Steele, R Duane, Davis, Scott M, Palmer
Publikováno v:
Chest. 124(4)
Posttransplant lymphoproliferative disorder (PTLD) is a relatively infrequent but devastating complication that occurs after solid-organ transplantation. Although the optimal treatment for this condition is unknown, rituximab, a murine/human chimeric